LSTM faces redundancy risk as it tries to close an £8m funding gap
Potential job losses are now on the table at the Liverpool School of Tropical Medicine as the institution moves to reduce costs and protect its long-term viability. The warning lands at a difficult moment for a school with deep roots in global health research, clinical education and infectious disease science, where staffing capacity is inseparable from the work itself.
The University and College Union says a voluntary severance process has already taken place and that significant redundancies are being considered. Its account points to savings of around £8m in the current financial year, with similar reductions planned across the next two years. In a sector already under strain, that scale of cost cutting is not a bookkeeping exercise; it threatens the research staff, teaching expertise and specialist clinical skills that institutions like LSTM rely on to function.
A single laboratory or academic post can carry far more than one job description. In tropical medicine, staffing often supports multiple roles at once: designing studies, training students, maintaining international collaborations and translating research into practice in settings where infectious disease burden remains high.
A rare institution with a broad public health role
Founded in 1898, LSTM became the first institution in the world dedicated to research and teaching in tropical medicine. That history matters because the school’s remit is not narrow or symbolic. It conducts research into infectious diseases and global health and has built an international reputation through education, research and clinical work.
That mix of responsibilities makes workforce reductions especially consequential. A cut in one area can ripple across several others, slowing research delivery, narrowing student support and weakening specialist capacity at precisely the point when global health threats continue to demand deep expertise. For a school whose mission depends on sustained scientific continuity, uncertainty over posts can affect more than morale.
Jo Grady, the UCU general secretary, said any cuts would affect not only the staff directly involved but also student experience and the region’s research capacity. She urged management to be more open about its plans, rule out job cuts and work with unions to secure a stable future for the institution in Liverpool and the wider North West.
The warning from the union is blunt because the stakes are structural. When specialist academic units shrink, the loss is often cumulative: fewer staff mean fewer projects, fewer projects mean less external funding, and less funding can trigger further retrenchment. That dynamic is familiar across higher education, but it is particularly acute in a field where expertise is highly specialised and difficult to replace quickly.
Management says further cuts are needed to stay sustainable
LSTM has acknowledged serious financial pressure and says it must reduce its recurrent cost base if it is to remain sustainable. Its position is framed in the language of survival rather than expansion. The institution says it is facing some very difficult decisions, including potential redundancies, and has committed to full consultation before any final decisions are made.
The school also says it is actively working with three trade unions, including UCU. That matters because consultation is where the next phase of the dispute will likely be shaped: whether leaders can identify savings without eroding the academic and scientific functions that define the institution, or whether union pressure forces a different approach.
A short sentence captures the central tension.
Savings and research capacity are pulling in opposite directions.
Why the financial pressure carries wider health implications
LSTM is not a conventional university department. Its work sits at the intersection of research, training and clinical relevance, with an international footprint in infectious diseases and global health. Cuts in that environment can have consequences that extend well beyond the campus. Students may face a thinner educational offer, while ongoing research programmes could lose momentum if experienced staff leave or if recruitment is frozen.
That concern becomes more acute when a school is trying to hold on to specialist expertise. Infectious disease research depends on continuity, long project timelines and teams that understand both the science and the operational realities of global health work. Once those teams are fragmented, rebuilding them is slow and expensive.
The timing also follows a major capital announcement. Last month, LSTM unveiled a new £20m robotic laboratory designed to accelerate the development of drugs, vaccines and diagnostics. Supporters of that project said it could create hundreds of technology jobs when it becomes fully operational in 2027. The contrast is stark: long-term ambition in one part of the institution, immediate financial retrenchment in another.
Consultation will determine how far the cuts reach
For now, no final redundancy decisions have been announced. The institution has pledged to consult fully with staff, and the next phase will determine whether it can find savings without permanently weakening its core academic mission.
The dispute also reflects a broader pressure point across higher education, where organisations with global reputations are still exposed to recurring cost pressures and difficult staffing choices. At LSTM, however, the issue is sharper because the school’s identity is built around specialist research capacity. Once that capacity is reduced, the effects can be felt in grant income, student training and regional scientific influence.
The question is no longer whether LSTM faces financial strain. It does. The unresolved issue is how much of its specialist workforce can be preserved while the school tries to close an £8m gap this year and similar gaps in the years ahead.